Work

Epidermal Growth Factor Receptor (EGFR)-Mediated Adverse Events (AEs) in Patients (pts) With EGFR-Mutation Positive (EGFR M+) Non-Small Cell Lung Cancer (NSCLC) Treated With Afatinib (A)

Year: 2014

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2014.08.223

Authors: Y. Wu, S.L. Geater, T. Mok, K.J. O'Byrne, M.H. Schuler, L.V. Sequist, J.C. Yang, D. Massey, D. O’Brien, V. Zazulina

Institutions: Guangdong General Hospital, Prince of Songkla University, Chinese University of Hong Kong, Princess Alexandra Hospital, University of Duisburg-Essen, Massachusetts General Hospital, National Taiwan University Hospital, Boehringer Ingelheim (United Kingdom), Boehringer Ingelheim (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1994017124

FWCI:

Cites:

Cited by: 1

Related to: 10